RxDoctor Payments DataLook up a doctor →

Amanda Mixon, PA

Medical · Fort Collins, CONPI 1174795017

Payments from drug & device makers

$341,961in general payments, 2019–2025

Across 690 payments — averaging $495.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$153K
  • Lilly USA, LLC$56K
  • Janssen Scientific Affairs, LLC$40K
  • Johnson & Johnson$28K
  • Amgen$15K
  • Sanofi$12K
  • plus $38K from 11 others
$6,563in research payments, 2019–2025

Across 1 payment — averaging $6563.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$7K

What the payments were for

  • Consulting fees$46,35214%
  • Speaking & faculty fees$197,52758%
  • Travel & lodging$83,32524%
  • Food & beverage$14,6584%
  • Education$990%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie282$153,464
Lilly USA, LLC128$55,668
Janssen Scientific Affairs, LLC48$40,218
Johnson & Johnson49$27,766
Amgen(2 entities)43$14,578
Sanofi38$11,912
AstraZeneca44$11,036
Boehringer Ingelheim20$10,318
Pfizer7$7,462
Eli Lilly2$4,500
Novartis11$2,766
UCB, Inc.8$1,337
Avion Pharmaceuticals1$465
GSK5$259
Sanofi-aventis U.S. LLC1$90
Boston Scientific2$66
E.r. Squibb & Sons, L.L.C.1$56

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$341,961 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$639,684
Medicare patients
183
Services billed
24,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Orencia ClickjectAbatacept22$125,759
EnbrelEtanercept13$109,808
Humira(Cf) PenAdalimumab11$76,538
KevzaraSarilumab13$56,932
Hydroxychloroquine Sulfate209$8,200
MethotrexateMethotrexate Sodium121$2,953
Febuxostat18$1,556
Prednisone156$1,238
Duloxetine Hcl38$770
Leflunomide13$757
Gabapentin40$709
Allopurinol34$569
Celecoxib39$478
Folic Acid20$248
Azathioprine11$229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel$14,578$109,80813 claims
SanofiKevzara$11,912$56,93213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 766 medical providers in Colorado.

Other medical in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →